CHRO

Roche Holding AG Faces Growth Challenges Amidst Competition and Regulatory Risks, Downgraded to Underweight

PremiumRatings

4h ago

Trump Weekly: President says raising tariffs on India ‘substantially’

PremiumThe Fly

3d ago

AEO

PremiumThe Fly

Trump says separate tariff announcements coming for semi chips, pharmaceuticals

3d ago

AMD

PremiumThe Fly

Sonnet BioTherapeutics expands clinical evaluation of SON-1010 dose escalation

4d ago

SONN

PremiumThe FlyRoche announces data from Phase 3 Portal study of Susvimo

7d ago

Trump posts letters calling on drug company CEOs to lower prices

The Fly

Trump posts letters calling on drug company CEOs to lower prices

8d ago

AZN

BMY

Press Secretary says Trump sent letters today to pharmaceutical companies

Roche says 760 ambulatory DMD patients treated with Elevidys with no deaths

The Fly

Press Secretary says Trump sent letters today to pharmaceutical companies

8d ago

AZN

BMY

PremiumThe Fly

10d ago

Roche says set to resume shipments of Sarepta’s Elevidys outside U.S.

PremiumThe Fly

10d ago

Trump administration mulls charging patent holders 1%-5% fee, WSJ reports

PremiumThe Fly

11d ago

AZN

BMY

PremiumThe Fly

Roche price target raised to CHF 230 from CHF 220 at JPMorgan

11d ago

PremiumThe FlyGenentech to present new data from Alzheimer’s development portfolio

11d ago

Roche plans to test if new medicine can prevent AD symptoms, Bloomberg says

The Fly

Roche plans to test if new medicine can prevent AD symptoms, Bloomberg says

12d ago

Roche says will work with EMA on path forward for Elevidys

The Fly

Roche says will work with EMA on path forward for Elevidys

14d ago

European Union committee recommends against Sarepta’s Elevidys

PremiumThe Fly

14d ago

Brazil suspends sales of Sarepta’s Elevidys after deaths

PremiumThe Fly

14d ago

Sarepta price target lowered to $35 from $40 at Jefferies

PremiumThe Fly

15d ago

Roche says Brazilian death unrelated to Elevidys, Bloomberg reports

PremiumThe Fly

15d ago

PremiumThe FlyRoche says Elevidys benefit-risk in ambulatory patients remains positive

15d ago

H.C. Wainwright sees rejection for Sarepta in Europe tomorrow

The Fly

H.C. Wainwright sees rejection for Sarepta in Europe tomorrow

15d ago

Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges

Ratings

Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges

15d ago